Skip to content

Prediction of neoadjuvant chemotherapy for breast cancer by gut microbiota

Prediction of neoadjuvant chemotherapy for breast cancer by gut microbiota

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056669
Enrollment
Unknown
Registered
2022-02-10
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Good efficacy group/poor efficacy group:None

Sponsors

The First Affiliated Hospital of University of Science and Technology of China(Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-70 years; 2. Puncture pathology confirmed breast cancer, and neoadjuvant chemotherapy was performed; 3. After neoadjuvant chemotherapy, surgical treatment was performed.

Exclusion criteria

Exclusion criteria: 1. Have used various antibiotics, prebiotics, probiotics or lactic acid products within three months; 2. Have a history of alcohol abuse for more than 2 years, and a perennial smoking history; 3. Pregnancy or lactation; 4. Have oral, respiratory and gastrointestinal diseases; 5. Have other metabolic diseases, such as obesity, hypertension, diabetes, stones, various liver diseases, etc; 6. Have other autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, etc; 7. There is a history of gastrointestinal surgery or other recent types of surgery; 8. Have a family history of genetic disease, mental disease, etc; 9. The research object is participating in other research topics; 10. The researcher believes that other reasons are not suitable for continuing clinical trial.

Design outcomes

Primary

MeasureTime frame
Miller-Payne score;

Countries

China

Contacts

Public ContactMa Xiaopeng

South Area of the First Affiliated Hospital of University of Science and Technology of China (South Area of Anhui Provincial Hospital)

doc_mxp@126.com+86 15077904628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026